Hemostatic Factors as Druggable Targets in Diverse Pathologies

被引:0
|
作者
McDowell, Susan A. [1 ]
机构
[1] Ball State Univ, Biotechnol Program, Muncie, IN 47396 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1440 / 1440
页数:1
相关论文
共 50 条
  • [1] Identifying Druggable Targets by Protein Microenvironments Matching: Application to Transcription Factors
    Liu, T.
    Altman, R. B.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2014, 3 (01):
  • [2] Druggable Targets in Endocannabinoid Signaling
    Gregus, Ann M.
    Buczynski, Matthew W.
    DRUGGABLE LIPID SIGNALING PATHWAYS, 2020, 1274 : 177 - 201
  • [3] Viral life cycle of hepatitis B virus: Host factors and druggable targets
    Morikawa, Kenichi
    Suda, Goki
    Sakamoto, Naoya
    HEPATOLOGY RESEARCH, 2016, 46 (09) : 871 - 877
  • [4] Mitochondrial Potassium Channels as Druggable Targets
    Wrzosek, Antoni
    Augustynek, Bartlomiej
    Zochowska, Monika
    Szewczyk, Adam
    BIOMOLECULES, 2020, 10 (08) : 1 - 19
  • [5] IDENTIFICATION OF DRUGGABLE MOLECULAR TARGETS IN MENINGIOMA
    Anh Tran
    Zhang, Lyndsee
    Sahm, Felix
    Scholtens, Denise
    Horbinski, Craig
    NEURO-ONCOLOGY, 2019, 21 : 66 - 66
  • [6] EMERGING DRUGGABLE TARGETS IN COLORECTAL CANCER
    Di Nicolantonio, F.
    ANNALS OF ONCOLOGY, 2014, 25
  • [7] Druggable genetic targets in endometrial cancer
    Lehrer, Steven
    Rheinstein, Peter H.
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 30
  • [8] Druggable epigenetic targets in hepatoblastoma.
    Burra, Patrizia
    Tacke, Frank
    Ratziu, Vlad
    Zeuzem, Stefan
    Sangro, Bruno
    Angeli, Paolo
    JOURNAL OF HEPATOLOGY, 2023, 79 (04)
  • [9] Druggable Targets in Cytokine Release Syndromes
    Luri-Rey, Carlos
    Eguren-Santamaria, Inaki
    Matos, Ignacio
    Berraondo, Pedro
    Melero, Ignacio
    CLINICAL CANCER RESEARCH, 2023, 29 (21) : 4320 - 4322
  • [10] New druggable targets in the Ras pathway?
    Matallanas, David
    Crespo, Piero
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (06) : 674 - 683